Serum Growth Differentiation Factor 15 (GDF15) Levels Reflect Ischemic Etiology in Heart Failure Patients with Iron Deficiency: A Cross-Sectional Study
Biomolecules · 2025
DOI: 10.3390/biom15091234 ↗Kurz gefasst
Querschnittstudie in der Zeitschrift Biomolecules, 2025. Verfasst von Marta Tajes und 14 weiteren Autor:innen. Beteiligte Einrichtung: Bio-Heart Cardiovascular Diseases Research Group, Bellvitge Biomedical Research Institute (IDIBELL), L'Hospitalet de Llobregat, 08908 Barcelona, Spai…. Hauptthemen laut MEDLINE: Growth Differentiation Factor 15, Heart Failure, Iron Deficiencies, Myocardial Ischemia. Die Arbeit nennt 54 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Departament de Recerca i Universitats, Centro de Investigación Biomédica en Red Diabetes y Enfermedades Metabólicas Asociadas, Department of Research and Universities of the Generalitat of Catalonia.
Themen: Herzinsuffizienz
Abstract (Originalsprache)
Heart failure (HF), particularly of an ischemic etiology, is steadily increasing worldwide. Non-anemic iron deficiency (ID) is highly prevalent among HF patients, and it has been related to worse outcomes. Growth differentiation factor 15 (GDF15) has been related to atherosclerotic cardiovascular (CV) disease, HF and iron pathophysiology. Nevertheless, the specific potential role of GDF15 in HF patients with ID has not been fully explored. In this cross-sectional study we determined serum GDF15 levels in 60 HF patients with ID from the IRON-PATH II study. The discriminative capacity of GDF15 in logistic regression models for classifying these patients according to ischemic etiology was defined as the primary endpoint. Additionally, relationships between GDF15 levels and impaired right ventricle function, impaired functional capacity and HF were included as secondary endpoints. GDF15 was inversely related to tricuspid annular plane systolic excursion (TAPSE) and the six-minute walking test (6MWT), and positively related to hallmarks of HF [i.e., N-terminal prohormone of brain natriuretic peptide (NT-proBNP)] and other molecules influenced by HF progression [i.e., creatinine and ferritin]. Moreover, GDF15 was inversely related to hemoglobin, suggesting a potential link to iron homeostasis. Furthermore, GDF15 showed good classification capacity and improved the accuracy of a logistic regression model for ischemic HF classification in patients with ID. Overall, the findings of this study propose serum GDF15 levels as a potential tool for the classification of HF patients with ID according to the ischemic etiology.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Bio-Heart Cardiovascular Diseases Research Group, Bellvitge Biomedical Research Institute (IDIBELL), L'Hospitalet de Llobregat, 08908 Barcelona, Spain.
- Centro de Investigación Biomédica en Red de Enfermedades Cardiovasculares (CIBERCV), Instituto Salud Carlos III, 28029 Madrid, Spain.
- Community Heart Failure Program, Cardiology Department, Bellvitge University Hospital, L'Hospitalet de Llobregat, 08907 Barcelona, Spain.
- Department of Clinical Sciences, School of Medicine, Universitat de Barcelona, 08007 Barcelona, Spain.
- Research Unit on Lipids and Atherosclerosis, University Rovira i Virgili, 43201 Reus, Spain.
- Vascular Medicine and Metabolism Unit, "Sant Joan de Reus" University Hospital, 43204 Reus, Spain.
ORCID-Profile: Maria Del Mar Ras-Jiménez, Josefa Girona, Raúl Ramos-Polo, Montse Guardiola, José Manuel García-Pinilla, Josep Ribalta, Lluís Masana, Javier de Juan-Bagudá, Cândida Fonseca, Manuel Vázquez-Carrera, Josep Comin-Colet, Ricardo Rodríguez-Calvo
Förderung
- Departament de Recerca i Universitats
- Centro de Investigación Biomédica en Red Diabetes y Enfermedades Metabólicas Asociadas
- Department of Research and Universities of the Generalitat of Catalonia
- CIBER (Consorcio Centro de Investigación Biomédica en Red)
Zitieren
APA
Tajes, M., Ras-Jiménez, M. D. M., Girona, J., Ramos-Polo, R., Guardiola, M., García-Pinilla, J. M., Ribalta, J., Cobo-Marcos, M., Masana, L., de Juan-Bagudá, J., Fonseca, C., Enjuanes, C., Vázquez-Carrera, M., Comin-Colet, J., & Rodríguez-Calvo, R. (2025). Serum Growth Differentiation Factor 15 (GDF15) Levels Reflect Ischemic Etiology in Heart Failure Patients with Iron Deficiency: A Cross-Sectional Study. Biomolecules. https://doi.org/10.3390/biom15091234
Vancouver
Tajes M, Ras-Jiménez MDM, Girona J, Ramos-Polo R, Guardiola M, García-Pinilla JM, et al. Serum Growth Differentiation Factor 15 (GDF15) Levels Reflect Ischemic Etiology in Heart Failure Patients with Iron Deficiency: A Cross-Sectional Study. Biomolecules. 2025. doi:10.3390/biom15091234
BibTeX
@article{Tajes2025,
author = {Tajes, Marta and Ras-Jiménez, Maria Del Mar and Girona, Josefa and Ramos-Polo, Raúl and Guardiola, Montse and García-Pinilla, José Manuel and Ribalta, Josep and Cobo-Marcos, Marta and Masana, Lluís and de Juan-Bagudá, Javier and Fonseca, Cândida and Enjuanes, Cristina and Vázquez-Carrera, Manuel and Comin-Colet, Josep and Rodríguez-Calvo, Ricardo},
title = {Serum Growth Differentiation Factor 15 (GDF15) Levels Reflect Ischemic Etiology in Heart Failure Patients with Iron Deficiency: A Cross-Sectional Study},
journal = {Biomolecules},
year = {2025},
doi = {10.3390/biom15091234}
}
EUVIMED